An omission was made in the 1 February 2009 issue of the journal (Neofytos D, Horn D, Anaissie E, Steinbach W, Olyaei A, Fishman J, Pfaller M, Chang C, Webster K, Marr K. Epidemiology and Outcome of Invasive Fungal Infection in Adult Hematopoietic Stem Cell Transplant Recipients: Analysis of Multicenter Prospective Antifungal Therapy (PATH) Alliance Registry. Clin Infect Dis 2009; 48:265–73). The authors failed to acknowledge the role of 2 companies that contributed to the work. In the Acknowledgements section, the following information should have been added: “We would like to acknowledge Astellas Pharma US (APUS) for their generous support, Axiom Real-Time Metrics (Axiom) for their expertise in registry management, and the many dedicated coordinators at each site. As the financial sponsor of the PATH Alliance, APUS observed but did not influence the design of the PATH Alliance registry by the independent Scientific Advisory Board. APUS contracts Axiom to provide overall management services for the PATH Alliance registry, comprising data management, site support, application and database hosting, administrative management, and data extraction and analysis. APUS also sponsored Axiom's services for this individual research project; these services were comprised of data extraction, facilitation of statistical analyses, preparation of figures, and manuscript review.” The authors regret this error.

Editor's note. The Journal takes seriously issues of conflicts of interest, and the editors are disappointed that the authors did not disclose these relationships prior to publication, as required by Journal policy.

Comments

0 Comments